Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03054779 · ClinicalTrials.gov registry record · NA
Canola Oil Multi-center Intervention Trial II
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03054779: Completed NA study, sponsored by Penn State University.
NCT03054779 is a NA study that has completed, run by Penn State University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03054779, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Building on the findings from the investigators previous study, COMIT I, the purpose of the COMIT II study is to supplement the DEXA measurement of body composition with a supplementary DEXA measurement of visceral adipose tissue and to specifically target the impact of oleic acid consumption on body composition as the primary objective. COMIT II also will include analysis of fatty acid ethanolamines (FAEs) and their precursors to elucidate the mechanisms by which canola oil may be modifying body composition, measurement of endothelial function, inflammatory, adiposity and insulin sensitivity biomarkers, and genetic analyses.
Primary Outcome
Will be measured using DXA
Interventions
- OTHER Canola Oil
- OTHER High oleic acid canola oil
- OTHER Western diet oil combination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT03054779 record still lists
NCT03054779 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Canola Oil is the first listed.
NCT03054779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03054779 about?
NCT03054779 is a clinical study titled "Canola Oil Multi-center Intervention Trial II". Building on the findings from the investigators previous study, COMIT I, the purpose of the COMIT II study is to supplement the DEXA measurement of body composition with a supplementary DEXA measurement of visceral adipose tissue and to specifically target the impact of oleic acid consumption on bod...
What is the current status of trial NCT03054779?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-09. Estimated completion is 2016-11.
What interventions are being tested in trial NCT03054779?
The interventions under investigation include: Canola Oil (OTHER), High oleic acid canola oil (OTHER), Western diet oil combination (OTHER).
Who is sponsoring clinical trial NCT03054779?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03054779's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia